BMJ  2007;334:1283-1284 (23 June), doi:10.1136/bmj.39217.382836.BE

Editorials

blockers and statins in non-cardiac surgery

Routine use to prevent perioperative cardiac complications is not evidence based

The first 150 words of the full text of this article appear below.

Globally, about 100 million adults have non-cardiac surgery each year. In the United States, perioperative cardiac complications occur in 0.5-1%, so around one million patients risk cardiac complications and about a quarter will die each year.^{1 2} Outcomes in Europe are similar to the US.³ Anaesthetists have progressively changed the emphasis on reducing perioperative cardiovascular risk from assessing preoperative coronary artery anatomy to understanding the pathophysiology of perioperative myocardial ischaemia. Despite efforts to identify risk factors for perioperative myocardial ischaemia and potential therapeutic options in the perioperative period, the benefit of giving blockers and statins at this time remains unclear.^{2 4 5}

Since the early studies that incorrectly attributed survival benefits to perioperative treatment with blockers,⁶ rigorous meta-analysis confirmed the need for a large multicentre randomised placebo controlled trial.⁵ Since then, 1520 patients have been randomised to three studies that have shown no benefit from perioperative metoprolol.^{7 8 9}

The diabetic postoperative mortality and morbidity . . . [Full text of this article]

¹ Department of Clinical and Biomedical Sciences, University of Melbourne, VIC 3220, Australia, ² Department of Perioperative Medicine, Anaesthesia and Pain Management, Geelong Hospital, Geelong, VIC 3220, Australia

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Evidence to inform

Fiona Godlee
BMJ 2007 334: 0. [Extract] [Full Text]

Changing what we do

Douglas Kamerow
BMJ 2007 334: 0. [Extract] [Full Text]

Effect of perioperative blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial

Anne Benedicte Juul, Jørn Wetterslev, Christian Gluud, Allan Kofoed-Enevoldsen, Gorm Jensen, Torben Callesen, Peter Nørgaard, Kim Fruergaard, Morten Bestle, Rune Vedelsdal, André Miran, Jon Jacobsen, Jakob Roed, Maj-Britt Mortensen, Lise Jørgensen, Jørgen Jørgensen, Marie-Louise Rovsing, Pernille Lykke Petersen, Frank Pott, Merete Haas, Rikke Albret, Lise Lotte Nielsen, Gun Johansson, Pia Stjernholm, Yvonne Mølgaard, Nikolai Bang Foss, Jeanie Elkjær, Bjørn Dehlie, Klavs Boysen, Dusanka Zaric, Anne Munksgaard, Jørn Bo Madsen, Bjarne Øberg, Boris Khanykin, Tine Blemmer, Stig Yndgaard, Grazyna Perko, Lars Peter Wang, Per Winkel, Jørgen Hilden, Per Jensen, Nader Salas DIPOM Trial Group
BMJ 2006 332: 1482. [Abstract] [Full Text] [PDF]

blockers for patients at risk of cardiac events during non-cardiac surgery

Stephen Bolsin and Mark Colson
BMJ 2005 331: 919-920. [Extract] [Full Text] [PDF]

How strong is the evidence for the use of perioperative blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials

P J Devereaux, W Scott Beattie, Peter T-L Choi, Neal H Badner, Gordon H Guyatt, Juan C Villar, Claudio S Cinà, Kate Leslie, Michael J Jacka, Victor M Montori, Mohit Bhandari, Alvaro Avezum, Alexandre B Cavalcanti, Julian W Giles, Thomas Schricker, Homer Yang, Carl-Johan Jakobsen, and Salim Yusuf
BMJ 2005 331: 313-321. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Perioperative beta blockade for high risk vascular patients

Adam C Pichel
bmj.com, 25 Jun 2007 [Full text]

The routine use of beta-blockade and statin therapy to prevent cardiac complications in patients undergoing non-cardiac surgery.

Andrew J Turley, et al.
bmj.com, 12 Jul 2007 [Full text]

Online poll

Find out more here>> and here>>